TF is highly expressed in the leading edge of tumors; circulates in the blood of cancer patients; contributes to malignancy-associated thrombosis; and can promote cancer cell proliferation and metastasis through non-hemostatic signaling [17,18,19,20]. This evidence concerns the gene TF and cancer.